glp-1 substance use disorder GLP1 receptor agonists may reduce addictive behaviors | JAMA Psychiatry posted on the topic GLP-1 drugs reduce addiction risk

It binds to IGF-1 receptors on muscle and other cells, activating anabolic signaling pathways that stimulate protein synthesis, cell growth (hyperplasia), and tissue regeneration

Diabet Med 2009;26:268278

Themes Analysis resulted in the generation of three overarching themes related to experiences of patients taking GLP-1 receptor agonists (Fig

Properties: Chicoric Acid, Taraxasterol, Chlorogenic Acid

The results were impressive

Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level